Infant Care Innovation
Global Infant Catheter Market to Reach $3.02 Billion by 2033 Amid NICU Expansion
The global infant catheter market is worth $1.62 billion in 2025 and is on track to nearly double to $3.02 billion by 2033, according to Verified Market Research. That works out to a steady 8.1% annual growth rate over eight years — faster than most medical device categories.
Three forces are driving that growth: more neonatal intensive care units (NICUs) opening worldwide, hospitals adopting standard rules for which devices to buy, and manufacturers building safer, smarter catheters. A catheter is a thin tube doctors insert into a baby's body to deliver medicine, drain fluids, or monitor the heart.
NICUs Are Expanding and So Is Demand
About 1 in 33 babies is born with a heart defect, a urinary tract problem, or another condition that requires immediate catheterization, according to Market Research Future. NICU admissions in the U.S. climbed to 9.8% of all births in 2023, the American Hospital Association reported. Each admitted newborn needs specialized tubes to receive nutrition, medication, and fluids.
North America leads the world with roughly 40% of global market share. The NICU sub-segment alone was worth about $214.5 million in the region in 2025, according to Fortune Business Insights. Asia-Pacific is the fastest-growing region, with its interventional cardiology catheter segment projected to grow at 7.01% annually through 2034.
Safer Materials and Smarter Designs Replace Old Standards
Polyvinyl chloride (PVC) tubes still make up 52.2% of the pediatric catheter market, Verified Market Research found. But hospitals are quickly shifting to DEHP-free and antimicrobial-coated alternatives. DEHP is a chemical softener in PVC that raises health concerns in fragile newborns.
AI-guided placement systems already hit a 95% first-attempt success rate in some trials, according to Mordor Intelligence. That matters because even a fluid delivery error of less than 5 mL per hour can cause serious harm to a newborn, Cleveland Clinic Children's neonatologists have noted. Better placement tools reduce that risk and lower the workload on nurses.
Key Players Compete on Safety, Not Just Price
Becton, Dickinson and Company (BD) is the market leader. Its 2025 Corporate Sustainability Report says the company's strategy centers on "addressing the significant risk of bloodstream infections in NICUs." Teleflex and Cook Medical follow closely, focusing on device designs that make procedures faster and more consistent.
Medtronic called itself a "high-growth contender" in 2026. On its Q2 2026 earnings call, leadership said, "We're positioning ourselves for even greater acceleration in revenue growth." Verified Market Research analysts say winning in this market now depends on "compliance readiness, handling-centric design, and supply chain reliability" — not just the cheapest device.
Infection Risk, Skills Gaps, and Cost Still Hold the Market Back
Fortune Business Insights flags "substantial risk of infections and complications" as the top brake on growth. Newborns have very fragile veins and weak immune systems. Some hospitals choose to limit catheter use or try other methods when infection rates climb, slowing adoption especially in lower-income settings.
Two other problems compound the risk. A shortage of trained neonatal nurses means advanced catheters often cannot be placed safely, according to Metastat Insight. And 60% of American pediatric catheter users face significant out-of-pocket costs due to limited insurance coverage, the Spina Bifida Association reports, meaning the market's growth still skews toward wealthier patients and hospitals.
Sentiment
NeutralPublishers
5
Articles
4
Reach
5
